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Abstract
Background/Aims: Proliferative diabetic retinopathy
is characterized by the formation of retinal
neovascularization. Angiopoietin-2 (Ang-2) and ma-
trix metalloproteinase (MMP) play a critical role in an-
giogenesis. However, the precise location and func-
tion of Ang-2 during formation of retinal neovasculari-
zations driven by hypoxia in relation to MMP activity
have not been elucidated. In this study, we investi-
gated the response of Ang-2 heterozygous knockout
retinas (Ang2+/- mouse) to hypoxia and its link to MMP
activity in an oxygen-induced retinopathy (OIR) model.
Methods: Pre-retinal neovascularizations were
quantitated in vertical sections. Intra-retinal angiogen-
esis was assessed by whole mount immunofluores-
cence staining of retinas. MMP activity was examined
in retinal protein lysate and whole mount retinal in
situ zymography. Results: Ang2+/- retinas subjected
to the OIR model showed 33 % reduced
neovascularization and 271 % increased avascular
zones at postnatal day 17. In the OIR model, Ang-2
was modestly expressed in pre-retinal
neovascularizations and venules, but strongly in
arterioles and capillary sprouts. MMPs were activated
in close association to where Ang-2 is expressed. MMP
activity was substantially decreased in Ang2+/- reti-
nas. Conclusions: Our present data suggest the spa-
tially concomitant expression of Ang2 and MMPs, and
that Ang2 modulates hypoxia-induced neovasculari-
zation by regulating MMP activity.
Introduction
Proliferative diabetic retinopathy is still the leading
cause of blindness in the working age all over the world
[1]. There is emerging evidence indicating that the
Angiopoietin-Tie2 system is involved in the pathogenesis
of diabetic retinopathy [2, 3]. Hyperglycemia up-regu-
lates angiopoietin-2 (Ang-2) expression prior to the mor-
phological changes of retinal capillaries in diabetic retin-
opathy. Pericyte loss is causally linked to elevated Ang-2
level in the retina. Pericytes are important for the protec-
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tion of endothelial cells against capillary damage. Loss of
pericytes is followed by degeneration of endothelial cells
and capillary occlusion [4]. Regression of retinal capil-
laries and insufficient oxygen supply lead to hypoxia-in-
duced lesions of the retina. Hypoxia-induced
neovascularization is the hallmark of proliferative diabetic
retinopathy (PDR). The newly formed blood vessels grow
on the inner limiting membrane of the retina towards the
vitreous. They are thin-walled and leaky, leading to exu-
dates and haemorrhages, causing severe vision loss and
even blindness in end stages of the disease. Ang-2 is el-
evated in vitreous fluid and epi-retinal membranes of pa-
tients with PDR [5, 6]. Furthermore, Ang-2 is upregulated
in experimental rodent retinas with hypoxia-induced
neovascularization (OIR) [7]. Vascular endothelial growth
factor (VEGF) is a major mediator in the hypoxia-induced
neovascularization [8, 9]. Expression of VEGF in con-
cert with Ang-2 under hypoxia induces retinal
neovascularizations [10, 11].
The mechanisms underlying Ang-2-involved retinal
neovascularization in proliferative diabetic retinopathy are
complex. The most important initial step in retinal
neovascularization is the degradation of the basement
membrane and extracellular matrix components surround-
ing the endothelial cells followed by invasion, migration
and proliferation of endothelial cells and final formation
of new vascular tubes [12]. Matrix metalloproteinases
(MMPs) are among the most potent regulators of angio-
genesis during extracellular matrix remodelling. MMP-2
and MMP-9 are upregulated in vitreous and epi-retinal
membrane of patients with PDR [13-15]. MMP activity
is increased in experimental rodent retinas of hypoxia-
induced neovascularization [16]. Reduction of retinal
neovascularization in MMP-2 and in MMP-9 null mice
and by MMP inhibitors suggests the importance of such
proteases in retinal neovascularization [13, 16]. Ang-
iogenic stimuli, such as VEGF and Ang-2, promote the
expression of MMPs [17, 18]. In tumor tissues,
upregulation of MMPs in the endothelial cells by Ang-2
may contribute to cell invasion [19]. MMPs colocalize
with Ang-2 in the invasive areas of glioma tissues, indi-
cating the synergistic effect of MMPs and Ang-2 in tumor
cell invasion [20, 21]. Furthermore, a study by Das et al.
suggested that Ang-2 stimulates MMP expression in cul-
tured endothelial cells in a dose dependent manner, and
blocking of the Ang-Tie2 system by soluble Tie-2, a com-
mon receptor for Ang-1 and its antagonist Ang-2 led to
decreased hypoxia-induced neovascularization and
MMP-9 expression in the OIR model [18].
Although Ang-2 and MMPs are detected in the
neovascularization areas in OIR [18, 22], little is
known about the precise requirement of Ang2 and MMP
activity in OIR. Furthermore, no detailed information is
available on the MMP activity related to decreased Ang-
2 in OIR. Using a Ang-2 heterozygous knockout mouse
(Ang2+/- mouse) in the OIR model, we investigated the
vascular response of Ang2+/- retinas to hypoxia, the ex-
pression of Ang-2 and activity of MMP under hypoxia in
Ang2+/- mouse using the reporter gene LacZ and whole
mount retinal in situ zymography, respectively.
Materials and Methods
Animals
The care and experimental use of all animals in the study
were in accordance with institutional guidelines and in compli-
ance with the Association for Research in Vision and
Ophthamology (ARVO) statement. Genotyping was performed
as described previously [23].
Analysis of retinal neovascularization in the OIR model
To study the vascular response of Ang2+/- retinas to
hypoxia, newborn Ang2+/- mice were subjected to 75 % oxygen
at postnatal day 7 (p7) for 5 days with their wild type littermates
and nursing mothers. Hyperoxia results in vasoregression in
the superficial capillary layer, while the deep capillary layer
does not exist at this time point. At p12, the mice were returned
to room air. Relative hypoxia from p12 to p17 leads to pre-
retinal neovascularization and intra-retinal vascular generation/
repair in the retinal superficial and deep capillary layer. At p17,
eyes were enucleated under deep anaesthesia. For
neovascularization analysis, eyes were immediately fixed in
formalin, then, embedded in paraffin. Serial sections of 6 μm
thickness were generated and the numbers of pre-retinal
neovascular nuclei per section were counted as described
previously [24].
LacZ staining
To assess the expression of Ang-2 in hypoxia, we used
the reporter gene LacZ in this mouse. Eyes were obtained from
Ang2+/- and their wild type littermates at p12 and p17 in OIR
model. They were first fixed with 0.2 % glutaraldehyde and 1.5
% formaldehyde in 100 mM phosphate buffer pH 7.3 for 20
minutes, then, retinas were enucleated. After washing, the reti-
nas were stained in a solution containing 0.1 % X-gal (Roche
Diagnostics GmbH, Mannheim, Germany), 5 mM K4Fe(CN)6,
and 5 mM K3Fe(CN)6 at 37°C for 6 hours. Finally, retinas were
washed in PBS and subjected to immunofluorescence stain-
ing.
Whole mount vessel immunofluorescence and
quantification of avascular zones
To evaluate avascular zones resulting from hyperoxia at
p12 and its alteration due to relative hypoxia at p17 in the OIR
model, eyes subjected to LacZ staining were subsequently
Feng/Wang/Pfister/Hillebrands/Deutsch/HammesCell Physiol Biochem 2009;23:277-284
279
stained with FITC-conjugated lectin (1:100, Sigma, Germany)
to visualize retinal vessels. Central avascular zones in the retina
(measured in µm2 per retina) were quantified by using an analy-
sis program (IM50, Leica BMR, Bensheim, Germany). To iden-
tify the colocalization of Ang-2 with pericytes, double staining
was performed. Vessels were recognized by TRITC-conjugated
lectin (1:100, Sigma, Germany) and pericytes were identified by
pericyte-specific marker rabbit anti-NG2 (1:200, Chemicon In-
ternational, Hampshire, UK) as first antibody and swine anti-
rabbit IgG conjugated with FITC as secondary antibody (1:20,
DakoCytomation GmbH, Hamburg, Germany).
Retinal digest preparation
Retinas of Ang2+/- mice from OIR model at p17 stained
with LacZ were fixed in 4 % paraformaldehyde for 24-48 hours.
Then, retinas were incubated in aqua bidest for 30 minutes.
Subsequently, the retinas were transferred to a 3 % trypsin
solution resolved in 0.2 M Tris buffer, pH 7.4, for 2-3 hours.
During digestion, vitreous with pre-retinal neovascularizations
of Ang2+/- retinas were carefully separated from intra-retinal
vessels, flat mounted on objective slides and finally stained
with PAS. The intra-retinal vasculature of Ang2+/- mice were
also washed in aqua bidest. To visualize the vascular sprouts
growing downwards to the deep capillary layer at p17 in the
OIR model, photos were taken during the washing step with
the focus on the deep capillary layer.
MMP Activity - Gelatinase/Collagenase assay
EnzChek Gelatinase/Collagenase Assay kit (Invitrogen
GmbH, Karlsruhe, Germany) was used to detect MMP activi-
ties in the retinas. The kit contains DQTM gelatine conjugated
with fluorescein. This substrate can be efficiently digested by
most gelatinases and collagenases to yield highly fluorescent
peptides. Protein lysates were generated from OIR retinas at
p17. 150 µg proteins were incubated in a reaction buffer con-
taining 50 mM Tris, 150 mM NaCl, 5 mM CaCl2, 0.2 mM sodium
azide with 20 µg DQ gelatine solution at room temperature.
Fluorescence was measured at multiple time points in a
fluorescence multi-well microplate reader set for excitation at
485 nm and emission at 530 nm. Clostridium collagenase and
1,10-phenanthroline were used for standard curve and MMP
inhibitor, respectively. One unit is defined as the amount of
enzyme required to liberate 1 µmole of L-leucine equivalents
from collagen in 5 hours at 37°C, pH 7.5.
Detection of specificity of activated MMP
20µg retinal proteins extracted from Ang2+/- p17 and WT
p17 mice subjected to OIR were incubated with loading buffer
without denaturation agents for 20 minutes on ice. The
proteins were separated a 10 % SDS gel copolymerized with 0.1
% gelatin (Sigma-Aldrich, Taufkirchen, Germany). After elec-
trophoresis, the gel was incubated in the zymogram renatura-
tion buffer (Bio-Rad, Munich, Germany) for 1 h and followed
by incubation in the zymogram development buffer (Bio-Rad,
Munich, Germany) at 37°C for 48 hours., Subsequently, the gel
was stained with 0.1 % coomassie blue R-250 (Serva,
Heidelberg, Germany) containing 30 % methanol and 10 %
acetic acid. Destaining was performed in a solution with 50 %
methanol and 10 % acetic acid. MMP activity was digitized as
transparent bands with Gel IX imager system (INTAS,
Göttingen, Germany).
Whole mount retinal in situ zymography
Detection of MMP activity was performed using EnzChek
Gelatinase/collagenase Assay kit supplied by Molecular Probes
(Invitrogen GmbH, Karlsruhe, Germany). Briefly, slides were
pre-coated with 0.5 mg/ml DQ gelatine conjugated with
fluorescein containing 0.1% agarose. Unfixed retinas of
Ang2+/- and wild type mice subjected to OIR at p17 were
isolated in cold PBS and whole mount mounted (ganglion cell
layer downwards to coated slide). The preparations were then
incubated in the reaction buffer at 37°C over night. Photos
were taken with a fluorescence microscope connected to a
digital camera (IM50, Leica BMR, Bensheim, Germany).
Statistic analysis
Data are expressed as mean ± SEM. Data analysis was
performed by using unpaired t-test with welsh correction.
A p value < 0.05 was considered as statistical significant.
Results
Decreased Ang-2 in the retina abrogates
neovascular response of retinal vessels to
hypoxia
We used the OIR model to study the impact of Ang-
2 on neovascularization in Ang2+/- mice at p17. First, pre-
retinal neovascularizations were evaluated. Ang2+/- mice
showed significantly reduced neovascularization in
response to hypoxia at p17 (0.67 ± 0.07) compared with
their wild type littermates (1.00 ± 0.09). The 50%
reduction of Ang-2 gene dosage resulted in a 33%
reduction of neovascularization in the retina (Fig. 1A-C).
At p7 when the mice were subjected to the OIR model,
Ang2+/- mice showed vascular development in the
superficial layer identical to wild type mice (not shown).
Next, intra-retinal angiogenesis was assessed by
measuring avascular zones in the retinas. Avascular zones
resulting from hyperoxia in the OIR model were ana-
lysed at p17. Avascular zones at p17 differed significantly
between Ang2+/- and wild type mice as depicted in
Fig. 1D and E. Ang2+/- mice had a 271 % larger avascu-
lar area in the central retina compared with wild type
mice (Fig. 1F). To determine whether decreased Ang-2
impairs the vasoregressive response in the OIR model,
we measured the avascular zones at p12, immediately
after the hyperoxic period when mice returned to room
air. Retinas of Ang2+/- and wild type mice were compa-
rable in the vascular zones at p12 (4.77 ± 0.47 mm2/retina
in Ang2+/- mice and 4.82 ± 0.60 mm2/retina in wild type
Ang-2 and MMP Activity in Hypoxia-Induced Neovascularisation Cell Physiol Biochem 2009;23:277-284
280
mice). The data suggested that Ang-2 plays a pivotal role
in hypoxia-induced angiogenesis, but not in vasoregression
under hyperoxia conditions in the OIR model.
To study the localization of Ang-2-expressing cells
in retinal vasculature in the OIR model, we used the re-
porter gene in the Ang2+/- mice. As displayed in Fig. 2,
Ang-2 was strongly expressed in vessels at p17 under
retinal hypoxia. Ang-2 expression is detected in some
capillaries in the periphery and in vessels at the border of
avascular zone in the retina (Fig. 2A and B), especially in
tortuous arterioles (Fig 2C), on sprouts of venules
(Fig. 2D) and on sprouts towards the deep capillary layer
(Fig. 2E). A scattered expression of Ang-2 was found in
pre-retinal neovascular tufts (Fig. 2F). For colocalization
of Ang-2 with vascular cells, immunofluorescence
staining was performed in the Ang2+/- retinas at p17 in
the OIR model. Lectin and NG2 were used to identify
retinal vessels and pericytes, respectively, and Ang-2
Fig. 1. Response of retinal ves-
sels of Ang2+/- mice in oxygen-in-
duced retinopathy mouse model.
Representative demonstration (A
and B) and quantification (C) of
neovascularization in wild type (A)
and Ang2+/- (B) mice at p17 in the
OIR model. Arrows in A and B: pre-
retinal neovascularizations. ILM:
inner limiting membrane; INL: in-
ner nuclear layer; ONL: outer nu-
clear layer. Whole mount retinas
stained with lectin-FITC (D-E)
showing avascular zone (az) in wild
type (D) and Ang2+/- (E) mice at p17
in the OIR model. F is the quantita-
tive analysis of avascular zones
displayed in D and E. Arrow in E
indicates arteriole stained positive for LacZ in Ang2+/- retinas. Values in wild type in each litter are normalized to 1. Data are
expressed in mean ± SEM. * p < 0.05, ** p < 0.01. WT: wild type mice; Ang2+/-: Ang2+/- mice. Scale bars: 50 µm (A and B), 200 µm
(D and E).
Fig. 2. Expression of Ang-2 under hypoxia in oxy-
gen-induced retinopathy mouse model. Repre-
sentative demonstration of retinal digest prepara-
tions of Ang2+/- OIR retinas at p17 stained with
LacZ. A shows an overview of ¼ retina with arte-
riole (a) venule (v) and avascular zone (az). Exam-
ples of vessels at border of avascular zone (B),
arteriole (C) venule (D), sprouts towards the deep
capillary layer (E) and pre-retinal
neovascularizations (F) are displayed. F presents
pre-retinal neovascularizations in the vitreous
additionally stained with PAS. Photographs A - E
were taken during washing step and E is focussed
on the sprouts towards the deep capillary layer. G
- H are double fluorescence analysis stained with
lectin-Tritc (G) to visualize vessels and NG2 (H) to
detect pericytes. Black points in G - H are LacZ-
positive cells under fluorescence microscope. I:
merged image of G and H. Arrows in E: sprouts
towards the deep retinal layer. Arrows in F: LacZ
weakly expressing pre-retinal tufts. Arrow in I:
pericyte. n=5. Scale bars: 200 µm (A), 50 µm (B - I).
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Fig. 3. Demonstration of MMP zymography gel of Ang2+/-
retina at p17 in the OIR model. A: representative blots; B:
Quantification of activity of MMP9 and MMP2. Ang2+/- retina
shows decreased pro- and active-MMP9 compared with wild
type retina. WT: wild type mice; Ang2+/-: Ang2+/- mice, AU:
arbitrary units. * p < 0.05, ** p < 0.01.
Fig. 4. Activity of MMPs in the Ang2+/- retinas at p17 in the
OIR model. Ang2LacZ+/- retinas (B, D, F, H) show decreased
MMP activity (green) compared with wild type retinas (A, C, E,
G).  A and B: the border of avascular zone, C and D: arterioles,
E and F: pre-retinal neovascularization, G and H: capillary
sprouts focused on the deep layer of the retina. az: avascular
zone, a: arteriole. Arrows in A and B: capillary sprouts at the
border of avascular zone. Arrows in E and F: neovascular tufts.
Arrows in G and H: capillary sprouts towards deep capillary
layer. The experiment was repeated twice. WT: wild type mice;
Ang2+/-: Ang2+/- mice. Scale bars: 50 µm.
expression was determined by LacZ staining. As shown
in Fig. 2G-I, expression of Ang-2 was detected in few
neovascular tufts and on sprouts. Expression of Ang-2
was not colocalized with pericyte marker NG2, suggest-
ing endothelial Ang-2 expression under hypoxia. Ang-2
was not detected in any vascular cell at p12 in the OIR
model under hyperoxia (data not shown).
Activity of MMP is reduced in the Ang2+/- retinas
under hypoxia
To examine the link between Ang-2 expression and
MMP activity, we analysed the alteration of MMP activ-
ity in Ang2+/- retinas using gelatinase/collagenase assay
with retinal total protein lysates and whole mount retinal
in situ zymography. In the gelatinase/collagenase assay,
Ang2+/- retinas at p17 in the OIR model showed signifi-
cantly decreased MMP activity in the whole retinal pro-
tein lysates compared with wild type retinas (Ang2+/-:
0.112 ± 0.014 mU/µg protein; wild type: 0.171 ± 0.013
mU/µg protein, n=10, p < 0.01). MMP9 and MMP2 are
the most abundant MMPs with gelatinase activity in the
retina. Therefore, we further addressed the identity of
MMPs regulated by hypoxia in Ang2+/- retinas. Both the
pro- and active-MMP9 decreased signicicantly at p17
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whereas pro- and active-MMP2 did not change in
Ang2+/- retinas compared with wild type retinas subjected
to the OIR model (Fig. 3). Furthermore, as displayed in
Fig. 4, strongly activated MMPs were detected at the
border of the avascular zone, i.e. where hypoxia-induced
intra-retinal remodeling predominantly occurred in wild
type mice. Arterioles and neovascularizations also dem-
onstrated high MMP activity. Apart from capillary sprouts
at the border of avascular zone, strong MMP activity was
seen in the capillary sprouts extending towards the deep
capillary layer. Activated MMPs in wild type retinas were
exclusively found in areas in which Ang-2 was expressed
(see corresponding Fig. 2). In Ang2LacZ+/- retinas in the
OIR model, the activity of MMPs was substantially lower
than in wild type retinas comparable with the results of
the zymography performed on whole lysates. A modest
staining intensity was observed in neovascularizations, in
the vessels at the border of avascular zones, in arterioles
and capillary sprouts towards the deep capillary layer,
indicating a largely decreased activity of MMPs under
reduction of Ang-2 in the OIR model.
Discussion
Our study demonstrates that a reduction in Ang-2
gene dose results in reduced activity of MMP9 at the
sites of angiogenic remodelling, and in decreased pre-
and intra-retinal angiogenesis.
The main finding in this study is the concomitant
spatial expression of Ang-2 and MMPs activity in the
hypoxia-induced retinal neovascularization model,
suggesting that Ang-2 and activated MMPs play a
permissive role in sprouting angiogenesis. Furthermore,
as the data in Ang2LacZ+/- mice indicate, decreased Ang-
2 gene dose with consecutive reduced activity of MMPs
leads to lower response of retinal vessels to hypoxia which
implicates that Ang-2 exerts its effect through activation
of MMPs in sprouting angiogenesis. Under hypoxia in
OIR, reduction of Ang-2 leads to decreased intra-retinal
angiogenesis indicated by increased avascular zone and
decreased pre-retinal neovascularization. Reduced
angiogenic response of Ang2+/- retinas in the OIR model
demonstrates that angiogenesis induced by hypoxia-driven
VEGF is modulated by Ang-2. Consistent with previous
observation in transgenic mice with overexpression of
Ang-2 in the retina which exhibit increased pre- and intra-
retinal angiogenesis [3], the data indicate the cooperative
role of Ang-2 with VEGF in vessel formation of both,
pre- and intra-retinal vessels.
We found that Ang-2 is predominantly expressed at
the leading edges of intra-retinal sprouts in the OIR model.
Our data also support previous studies showing that
 Ang-2 is expressed at the front of invading vascular
sprouts during vascular remodeling in the ovary [25]. In
the OIR model, localization of Ang-2 in pre-retinal
neovascularizations and intra-retinal capillaries has been
demonstrated [7]. Expression of Ang-2 in central artery
in the eye and in mesenteric arteries has been documented
in a study by Gale et al [23]. Our study demonstrates that
Ang-2 is localized in pre-retinal neovascularizations, in
arterioles, on the sprouts of venules and capillaries towards
the retinal deep layer. Taken together, these studies indicate
the particular significance of Ang-2 at the active
angiogenic front.
MMPs are activated in the OIR model and localized
in pre-retinal neovascularizations [18]. We found that
MMPs are dominantly active in arterioles and on the
vascular sprouts, similar to where Ang-2 is expressed.
The general role of combined Ang-2/MMPs activity is
further supported by data from invasive tumors. Elevated
Ang-2 in tumor cells caused activation of MMPs leading
to increased invasiveness of malignant tumors. High levels
of Ang-2 and MMPs are specifically found in invasive
areas of tumor sites [20]. A third example for the
collaboration of Ang-2 and MMPs in playing a role in
tissue remodeling is represented by sprouting angiogenesis
in adult skeletal muscle. Here, up-regulation of angiogenic
factors, such as VEGF and Ang-2, coincides with MMP
activity in the extracellular matrix [26]. Similarly, strong
intra-retinal activation of MMPs in arterioles, on the
vascular sprouts indicates that Ang-2 with adequate
activated MMPs is needed not only for pre-retinal
neovascularization, but also strongly in assembling the
intra-retinal vascular network. Requirement of Ang-2 and
activated MMPs in arterioles and on the sprouts is likely
dependent on high angiogenic and degradative demand
because of their special existing matrix components.
 In the OIR model, MMP2 and MMP9 are upregulated
[13]. More decreased neovascularizations by MMP2
selective inhibitor and in MMP2 deficient mice than by
MMP2+MMP9-selective inhibitor and in MMP9 deficient
mice suggest that MMP2 is likely a more dominant
mediator than MMP9 in formation of retinal
neovascularization in this model [27]. However, the study
by Das et al. demonstrated that angiopoietin-moderated
retinal neovascularization may be in part through the
inhibition of MMP9 expression [18]. Our data on
specificity of MMPs using loss of function of Ang-2
support the observation of Das and colleagues, indicating
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that Ang-2 exerts its effect through activation of MMP9.
However, the molecular mechanism(s) by which Ang-2
mediates MMP activation is unknown at present and
requires further investigations.
In conclusion, our study provides evidences that
VEGF-mediated angiogenesis under hypoxia is modulated
by Ang-2. Ang-2 and activated MMPs on the fronts of
angiogenesis play a critical role in proliferative retinopathy.
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